Arcutis Biotherapeutics
Price & Volume
Stats
See more52W Range | $15.13-$31.77 |
Market Cap | $3.1B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $463.9M |
Revenue Growth (YoY) | 59.3% |
Gross Profit (12 Mos) | $422.8M |
Diluted EPS | $0.22 |
News
See moreYahoo Finance • 22 days ago
Arcutis President and CEO Todd Watanabe Sells 4,375 Shares for $114,275 as Q2 Results Demonstrate Profitability
Yahoo Finance • 23 days ago
Arcutis raises 2026 net revenue guidance to $525M-$540M as ZORYVE demand expands and telehealth launches
Yahoo Finance • last month
Arcutis Expands Board of Directors with Appointment of Chris Peetz
Yahoo Finance • last month
Attovia Therapeutics Appoints John W. Smither to Board of Directors
About
CEO | Mr. Todd Franklin Watanabe M.A. |
Address | 3027 Townsgate Road, Westlake Village, CA, United States, 91361 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 354 |